International Clinical Trial: Effect of Sugammadex Sodium on Neuromuscular Blockade Reversal and Postoperative Recovery in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Controlled Trial

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122394) titled 'Effect of Sugammadex Sodium on Neuromuscular Blockade Reversal and Postoperative Recovery in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Controlled Trial' on April 13.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Condition: Pulmonary Nodule

Intervention: Sugammadex Group:Administration of sugammadex sodium at a dose of 2 mg/kg at TOF = 0.4 Neostigmine Group:Administration of 50 µg/kg neostigmine and 10 µg/kg atropine at TOF = 0.4

Recruitment Status: Not Recruiting

Phase: N/A

Da...